Clinical Trial Update: Anti-Platelets in Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating antiplatelet therapy in chronic obstructive pulmonary disease has completed. The study was conducted under Brigham and Women…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: COPD, Emphysema | Phase 2 | Status: COMPLETED